Funder
Swiss National Science Foundation
Reference5 articles.
1. Schwarzmüller, M., Schanz, M., Abela, I.A., Epp, S., Lozano, C., Curcio, M., Greshake, J., Rusert, P., Huber, M., Kouyos, R.D., et al. Decoupling HIV-1 Antiretroviral Drug Inhibition from Plasma Antibody Activity to Evaluate Broadly Neutralizing Antibody Therapeutics and Vaccines. Cell Rep. Med. 5, 101702. https://doi.org/10.1016/j.xcrm.2024.101702.
2. Optimization and Validation of a Neutralizing Antibody Assay for HIV-1 in TZM-bl Cells Using Luciferase Reporter Gen;Montefiori;J. Immunol. Methods,2009
3. Determinants of HIV-1 broadly neutralizing ntibody induction;Rusert;Nat. Med.,2016
4. HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry;Pugach;Virology,2007
5. Protein binding in antiretroviral therapies;Boffito;AIDS Res. Hum. Retroviruses,2003